Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Dec 2010

Liu Lingxiang, Shao Xiaoyan, Gao Wen, Bai Jianling, Wang Rongsheng, Huang Puwen, Yin Yongmei, Liu Ping, Shu Yongqian

Abstract excerpt

INTRODUCTION: Human epidermal growth factor receptor 2 (HER2) is regarded as a poor prognostic factor in many tumors. Conflicting data in many literatures were reported about the association between HER2 and poor prognosis in lung cancer. METHODS: We conducted a meta-analysis of published studies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Carcinoma, Small Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Amplification

Share to Immunohistochemistry

Share to In Situ Hybridization, Fluorescence

Share to Lung Neoplasms

Share to Publication Bias

Share to Receptor, ErbB-2

Source

Identifiers

PMID: 21155183
DOI: 10.1097/jto.0b013e3181f26266

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21155183-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data.PMID 21155183Read ↗

Prognostic value of epidermal growth factor receptor mutations in resected non-small cell lung cancer: a systematic review with meta-analysis.Semantic proximity Read ↗

Clinical characteristics and prognostic factors of patients with non-small cell lung cancer having HER2 alterations.Semantic proximity Read ↗

Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers.Semantic proximity Read ↗

HER2 and lung cancer.Semantic proximity Read ↗

Exploring adjuvant epidermal growth factor receptor inhibition in non-small cell lung cancer.Semantic proximity Read ↗

[Role of HER2 in NSCLC].Semantic proximity Read ↗

Epidemiological study of HER-2 mutations among EGFR wild-type lung adenocarcinoma patients in China.Semantic proximity Read ↗

The frequency and clinical impact of HER2 alterations in lung adenocarcinoma.Semantic proximity Read ↗

Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: a systematic review with meta-analysis.Semantic proximity Read ↗

Impact of HER2 expression on EGFR-TKI treatment outcomes in lung tumors harboring EGFR mutations: A HER2-CS study subset analysis.Semantic proximity Read ↗

Biological and clinical features in predicting efficacy of epidermal growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis.Semantic proximity Read ↗

Anaplastic lymphoma kinase gene rearrangement predicts better prognosis in NSCLC patients: A meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.